the 503A question that gets asked weekly, answered properly
Posting this as a discussion rather than a claim: the 503A question that gets asked weekly, answered properly. Salt form matters for mass: a preparation specified as one salt and dosed as the free base gives you a different amount of peptide for the same number on the label. A beyond-use date derived from published…
Paid noticeably more at one clinic than another for what turned out to be the same facility behind both.
Paid noticeably more at one clinic than another for what turned out to be the same facility behind both.
Adding one thing — ask for the facility name. Most will give it, and the ones that will not have answered you.
[deleted]
salt forms are the recurring argument and the answer is boring
That is not what patient-specific means. It refers to the prescription, not to a customisation of the formula.
a telehealth intake that asks nothing has told you what it is
Agreed. The 503A versus 503B distinction changes who is allowed to make what, and almost every confused thread here starts by ignoring it.
Yes. The shortage list is the legal hinge for the whole arrangement and its status is public.
ask what the beyond-use date is based on
Cosigning the beyond-use date question. What it is based on tells you whether anybody has done stability work.